SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-171020
Filing Date
2021-05-24
Accepted
2021-05-24 17:00:36
Documents
12
Period of Report
2021-05-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d74770d8k.htm   iXBRL 8-K 46623
  Complete submission text file 0001193125-21-171020.txt   174563

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vir-20210518.xsd EX-101.SCH 3090
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE vir-20210518_lab.xml EX-101.LAB 18138
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vir-20210518_pre.xml EX-101.PRE 11422
5 EXTRACTED XBRL INSTANCE DOCUMENT d74770d8k_htm.xml XML 3352
Mailing Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

IRS No.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39083 | Film No.: 21955827
SIC: 2836 Biological Products, (No Diagnostic Substances)